St John's wort and depression

Prescrire International

Volumn 13, Issue 73, 2004, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOSPORIN A; CYTOCHROME P450 3A4; DESIPRAMINE; DIGOXIN; FLUOXETINE; FLUVOXAMINE; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; IMMUNOSUPPRESSIVE AGENT; MAPROTILINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PLACEBO; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACROLIMUS; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; PLANT MEDICINAL PRODUCT;

CANCER; CLINICAL TRIAL; COLIC; CONFUSION; DEPRESSION; DISEASE SEVERITY; DROWSINESS; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; FATIGUE; FETUS DISEASE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HAMILTON SCALE; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; LIBIDO DISORDER; MANIA; META ANALYSIS; MOOD DISORDER; NEUROMUSCULAR DISEASE; NONHUMAN; PHOTODERMATOSIS; PREGNANCY; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEROTONIN SYNDROME; SIDE EFFECT; SOMNOLENCE; SWEATING; TACHYCARDIA; THROMBOSIS; WITHDRAWAL SYNDROME; XEROSTOMIA; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG INTERACTION; FRANCE; GERMANY; HYPERICUM; METHODOLOGY; PHYTOTHERAPY; TREATMENT OUTCOME; UNITED STATES;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG INTERACTIONS; FRANCE; GERMANY; HUMANS; HYPERICUM; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME; UNITED STATES;

EID: 15944395125     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Martin-Facklam M et al. "Quality markers of drug information on the internet: an evaluation of sites about St John's wort" Am J Med 2002; 113 (9): 740-745.
2. Prescrire Rédaction "Interaction entre médicaments et millepertuis" Rev Prescrire 2000; 20 (205): 281.
3. "Avis aux fabricants concernant les demands d'autorisation de mise sur le marché des médicaments à base de plantes" Journal Officiel, 2 March 2002: 4049-4051.
4. Prescrire Rédaction "Millepertuis: premières AMM allégées" Rev Prescrire 2002; 22 (234): 821.
5. Linde K et al. " St John's wort for depression. An overview and meta-analysis of randomised clinical trial" BMJ 1996; 313 (7052): 253-258.
6. Linde K and Mulrow CD "St John's wort for depression" (Cochrane review). In: "The Cochrane Library" John Wiley & Sons, Chischester 2003; Issue 4.
7. Kim HL et al "St John's wort for depression. A meta-analysis of well-defined clinical trials" J Nerv Ment Dis 1999; 187 (9): 532-539.
8. Schrader E et al. "Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study" Hum Psychopharmacol 1998; 13: 163-169.
9. Shelton RC et al. "Effectiveness of St John's wort in major depression. A randomized controlled trial" JAMA 2001; 285 (15): 1978-1986 + letters: 286 (1): 42-45.
10. Vorbach EU et al. "Efficacy and tolerability of St John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10" Pharmacopsyhiatry 1997; 30 (suppl. 2): 81-85.
11. Woelk H et al. "Comparison of St John's wort and imipramine for treating depression: randomised controlled trial" BMJ 2000; 321 (7260): 536-539.
12. Philipp M et al. "Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks" BMJ 1999; 319: 1534-1538.
13. Brenner R et al. "Comparison of an extract of Hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomised pilot study" Clin Ther 2000; 22 (4): 411-419.
14. Harrer G et al. "Comparisons of equivalence between the St John's wort extract LoHyp-57 and fluoxetine" Arzneimitteforschung 1999; 49 (4): 289-296.
15. Schrader E "Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomised, controlled study in mild-moderate depression" Int Clin Psychopharmacol 2000; 15 (2): 61-68.
16. Whiskey E et al. "A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review" Int Clin Psychopharmacol 2001 16 (5): 239-252.
17. Williams Jr JW et al. "A systematic review of newer pharmacotherapies for depression in adults: evidence report summary" Ann Intern Med 2000; 132 (9): 743-756.
18. Gaster B and Holroyd J "St John's wort for depression. A systematic review" Arch Intern Med 2000; 160 (2): 152-156.
19. Kalb R et al. "Efficacy and tolerability of Hypericum extract WS 5572 versus placebo in mildly moderately depressed patient. A randomized double-blind multicenter clinical trial" Pharmacopsychiatry 2001; 34 (3): 96-103.
20. Lecrubier Y et al. "Efficacy of St John's wort extract WS 5570 in major depression: double-blind, placebo-controlled trial" Am J Psychiatry 2002; 159 (8): 1361-1366.
21. Behnke K et al. "Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression" Adv Ther 2002; 19 (1): 43-52.
22. van Gurp G et al. "St John's wort sertraline? Randomised controlled trial in primary care" Can Fam Physician 2002; 48 905-912.
23. Hypericum Depression Trial Study Group "Effect of Hypericum perforatum (St John's wort) in major depressive disorder" JAMA 2002; 287 (14): 1807-1814 + letters 288 (4): 446-448.
24. Cosmetic Ingredient Review Expert Panel "Final report on the safe assessment of Hypericum perforatum extract and Hypericum perforatum oil" Int J Toxicol 2001; 20 (suppl.2): 31-39.
25. Klier CM et al. " St John's wort (Hypericum perforatum). Is it safe during breasfeeding?" Pharmacopsychiatry 2002; 35: 29-30.
26. Lee A et al. "The safety of St John's wort (hypericum perforatum) during breastfeeding" J Clin Psychiatry 2003; 64 (8): 966-968.
27. Stevinson C and Ernst E "Safety of Hypericum in patient with depression. A comparison with conventional antidepressants" CNS Drugs 1999; 11 (2): 125-132.
28. Hammersness P et al. "St John's wort: a systematic review of adverse effects and drug interactions for the consulation pychiatrist" Psychosomatic 2003; 44 (4): 271-282.
29. Ernst E et al. "Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.)" Eur J Clin Pharmacol 1998; 54 (8): 589-594.
30. Barnes J et al. "St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties" J Pharm Pharmacol 2001; 53 (5): 583-600.
31. Woelk H et al. "Benefits and risk of the Hypericum extract LI 160: drug monitoring study with 3 250 patients" J Geriatr Psychiatry Neurol 1994; 7 (suppl. 1): 34-38.
32. O'Breasail AM and Argouarch S "Hypomania and St John's wort" Can J Psychiatry 1998; 43 (7): 746-747.
33. Schneck C "St John's wort and hypomania" J Clin Pcychiatry 1998; 59 (12): 689.
34. Nierenberg AA et al. "Mania associated with St John's wort" Biol Psychiatry 1999; 46 (12): 1707-1708.
35. Moses EL and Malinger AG "St John's wort: three cases of possible mania induction" J Clin Psychopharmacol 2000; 20 (1): 115-117.
36. Güzelcan Y et al. "Manie tijdens het gebruik van een combinatiepreparaart met sint-janskruid (Hypericum perforatum)" Ned Tijdschr Geneeskd 2001; 145 (40): 1943-1945.
37. Fahmi M et al "A case of mania induced by hypericum" World J Biol Psychiatry 2002; 3 (1): 58-59.
38. Lal S et Iskandar H "St John's wort and schizophrenia" CMAJ 2000; 163 (3): 262-263.
39. Bhopal JS "St John's wort-induced sexual dysfunction" Can J Psychiatry 2001; 46 (5): 456-457.
40. Brown TM "Acute St John's wort toxicity" Am J Emerg Med 2000; 18 (2): 231-232.
41. Parker V et al. "Adverse reactions to St John's wort" Can J Psychiatry 2001; 46 (1): 77-79.
42. Patel S et al. "Hypertensive crisis associated with St John's wort" Am J Med 2002; 112 (6): 507-508.
43. Zullino D and Borgeat F "Hypertension induced by St John's wort. A case report" Pharmacopsychiatry 2003; 36 (1): 32.
44. Dean AJ et al. "Suspected withdrawal syndrome after cessation of St John's wort" Ann Pharmacother 2003; 37 (1): 150.
45. Golsch S et al. "Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskraut extrakt-Präparate" Hautarzt 1997; 48 (4): 249-252.
46. Bove GM "Acute neuropathy after exposure to sun in a patient treated with St John's wort" Lancet 1998; 352: 1121-1122.
47. Holme SA and Roberts DL "Erythroderma associated with St John's wort" Br J Dermatol 2000 143 (5): 1127-1128.
48. Lane-Brown MM "Photosensivity associated with herbal preparations of St John's wort (Hypericum perforatum)" Med J Aust 2000; 172 (6): 302.
49. Cotterill JA "Severe phototoxic reaction to laser treatment in a patient taking St John's wort" J Cosmet Laser Ther 2001; 3 (3): 159-160.
50. Ladner DP et al. "Synergistic toxicity of delta-aminolaevulinic acid-induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant" Br J Dermatol 2001; 144 (4): 916-918.
51. Observatoire national des prescriptions et consommations des médicaments, Agence du médicament "Étude de la prescription et de la consommation des antidépresseur en embulatoire"; July 1998; 29 pages. Summarised in. "Prescription et consommation des antidépresseur" Rev Prescrire 1999; 19 (194): 302.
52. Amar E and Balsan D "Les ventes d'antidepresseurs entre 1980 et 2001" Études et Résultants 2004; (285): 1-8.
53. Stevinson C and Ernst E "A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome" BJOG 2000; 107 (7): 870-876.
54. Grube B et al. "St John's wort extract: efficacy for menopausal symptoms of psychological origin" Adv Ther 1999; 16 (4): 177-186.
55. Taylor LH and Kobak KA "An open-label trial of St John's wort (Hypericum perforatum) in obsessive-compulsive disorder" J Clin Psychiatry 2000; 61 (8): 575-578.
56. Volz HP et al. "St John's wort extract (LI160) in somatoform disorders: results of a placebo-controlled trial" Psychopharmacology 2002; 164 (3): 294-300.
57. French medicines agency "Médicaments à base de plantes" Cahiers de l'Agence no 3, Paris 1998: 81 pages.